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Background
Although glucose is indispensable for the stimulation of
insulin release, numerous other insulin secretagogues
have been identified. For instance, the dietary monosac-
charide fructose potentiates insulin secretion in vitro,
but the mechanism and physiological significance
remains unclear. The T1R2-T1R3 heterodimer of G pro-
tein-coupled receptors mediates sweet sensing in the
tongue and ablation of either subunit obliterates sweet
taste. We hypothesized that the effects of fructose on
insulin release may be mediated by sweet taste receptors
(TRs) on beta-cells.
Materials and methods
Mice with the homozygous deletion for the T1R2, T1R3,
or TRPM5 gene (Dr. Zuker, Columbia University) were
bred and genotyped in-house. In vitro static insulin
release (ELISA, Mercodia) was assessed using cultured
human and mouse islets incubated in custom-made wells
with various treatments. Fura-2 based calcium imaging
was performed using MIN6 cells or dispersed mouse
beta-cells. Phospholipase C (PLC) activation was mea-
sured using Total Internal Reflection (TIRF) Microscopy
in transfected MIN6 cells with a PHPLCδ1-GFP construct.
In vivo experiments were performed with 8-10 week old
catheterized conscious male mice on regular chow after
5-hour fasting.
Results
Human and mouse islets express sweet TRs. Fructose
(10.0mM) rapidly activated PLC and increased intracellu-
lar calcium (Ca2+i) and insulin release at 8.3mM glucose
in wild type (WT) islets and MIN6 cells, but these effects
were absent in T1R2 knockout (T1R2-/-) islets. Similar to
mouse islets, fructose stimulated insulin release in
human islets and these effects were blocked by lactisole,
a human-specific inhibitor of T1R3. In vivo, an intrave-
nous bolus of fructose (1.0g/kg) rapidly increased plasma
insulin in WT, but not in T1R2-/- mice. Glucose-stimu-
lated insulin release (GSIS) in WT mice was potentiated
by low physiological concentrations of fructose (3.0mM
in vitro; 0.3g/kg in vivo), but these effects were absent in
T1R2-/- mice. The transient receptor potential channel
M5 (TRPM5) mediates TR signaling in the tongue, con-
tributing to cell membrane depolarization. Islets from
TRPM5 knockout mice (TRPM5-/-) failed to increase Ca2
+ and insulin release in response to fructose. Finally, the
expression of TRs is reduced in islets of diabetic mouse
models (db/db) and is associated with impaired fructose-
induced insulin release.
Conclusions
Fructose is a natural ligand for functional sweet TRs
expressed on mouse and human beta-cells. Pancreatic
taste receptors sense circulating fructose and activate a
distinct signaling pathway involving PLC, TRPM5 and
Ca2+I influx that potentiates GSIS [1]. Our data together
with previous reports showing that sweet TRs in the
intestinal epithelium stimulate dietary glucose absorption
and GLP-1 secretion, suggest a novel TR-dependent
intestinopancreatic axis that participates in the regulation
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of postprandial insulin release by absorbed sugars. These
data suggest a potential link between high-fructose con-
sumption and the development of adverse metabolic
effects. Interestingly, beta-cell TR expression and func-
tion is reduced in diabetic mouse phenotypes, also sug-
gesting that impaired TR signaling may play a role in the
pathogenesis of metabolic diseases.
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